Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sociodemographic factors associated with trajectories of depression among urban refugee youth in Kampala, Uganda: A longitudinal cohort study.
Admassu Z, Chen SS, Logie CH, Okumu M, MacKenzie F, Hakiza R, Musoke DK, Katisi B, Nakitende A, Kyambadde P, Mbuagbaw L. Admassu Z, et al. Among authors: nakitende a. Glob Ment Health (Camb). 2024 Dec 16;11:e125. doi: 10.1017/gmh.2024.135. eCollection 2024. Glob Ment Health (Camb). 2024. PMID: 39777003 Free PMC article.
Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment.
Aschmann HE, Musinguzi A, Kadota JL, Namale C, Kakeeto J, Nakimuli J, Akello L, Welishe F, Nakitende A, Berger C, Dowdy DW, Cattamanchi A, Semitala FC, Kerkhoff AD. Aschmann HE, et al. Among authors: nakitende a. J Int AIDS Soc. 2024 Dec;27(12):e26390. doi: 10.1002/jia2.26390. J Int AIDS Soc. 2024. PMID: 39587885 Free PMC article.
Tushirikiane-4-Uthabiti (Supporting Each Other For Resilience): study protocol of a mental health, HIV self-testing and livelihoods randomised controlled trial for advancing HIV prevention outcomes among urban refugee youth in Kampala, Uganda.
Logie CH, Okumu M, Tailor L, MacKenzie F, Admassu Z, Hakiza R, Kibuuka Musoke D, Katisi B, Nakitende A, Kyambadde P, Mbuagbaw L. Logie CH, et al. Among authors: nakitende a. BMJ Open. 2024 Nov 24;14(11):e087470. doi: 10.1136/bmjopen-2024-087470. BMJ Open. 2024. PMID: 39581739 Free PMC article.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Musinguzi A, Kasidi JR, Kadota JL, Welishe F, Nakitende A, Akello L, Nakimuli J, Kunihira LT, Opira B, Baik Y, Patel D, Sammann A, Berger CA, Aschmann HE, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PPJ, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A, Semitala FC, Katahoire AR. Musinguzi A, et al. Among authors: nakitende a. PLOS Glob Public Health. 2024 Oct 24;4(10):e0003347. doi: 10.1371/journal.pgph.0003347. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39446746 Free PMC article.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Musinguzi A, Kasidi JR, Kadota JL, Welishe F, Nakitende A, Akello L, Nakimuli J, Kunihira LT, Opira B, Baik Y, Patel D, Sammann A, Berger CA, Aschmann HE, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A, Semitala FC, Katahoire AR. Musinguzi A, et al. Among authors: nakitende a. medRxiv [Preprint]. 2024 Aug 22:2024.08.19.24308041. doi: 10.1101/2024.08.19.24308041. medRxiv. 2024. Update in: PLOS Glob Public Health. 2024 Oct 24;4(10):e0003347. doi: 10.1371/journal.pgph.0003347 PMID: 39314926 Free PMC article. Updated. Preprint.
Academic achievement in Ugandan children with sickle cell anaemia: A cross-sectional study.
Naggayi SK, Bangirana P, Opoka RO, Ouma S, Nyangoma B, Birabwa A, Nambatya G, Kabatabaazi M, Nakitende AJ, Kalibbala D, Munube D, Kasirye P, Mupere E, Ssenkusu JM, Green NS, Idro R. Naggayi SK, et al. Among authors: nakitende aj. medRxiv [Preprint]. 2024 Jul 8:2024.07.08.24309901. doi: 10.1101/2024.07.08.24309901. medRxiv. 2024. PMID: 39040208 Free PMC article. Preprint.
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda.
Musinguzi A, Aschmann HE, Kadota JL, Nakimuli J, Welishe F, Kakeeto J, Namale C, Akello L, Nakitende A, Berger C, Katamba A, Tumuhamye J, Kiwanuka N, Dowdy DW, Cattamanchi A, Semitala FC. Musinguzi A, et al. Among authors: nakitende a. IJTLD Open. 2024 Feb 1;1(2):83-89. doi: 10.5588/ijtldopen.23.0283. eCollection 2024 Feb. IJTLD Open. 2024. PMID: 38966690 Free PMC article.
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Semitala FC, Kadota JL, Musinguzi A, Welishe F, Nakitende A, Akello L, Kunihira Tinka L, Nakimuli J, Ritar Kasidi J, Bishop O, Nakasendwa S, Baik Y, Patel D, Sammann A, Nahid P, Belknap R, Kamya MR, Handley MA, Phillips PP, Katahoire A, Berger CA, Kiwanuka N, Katamba A, Dowdy DW, Cattamanchi A. Semitala FC, et al. Among authors: nakitende a. PLoS Med. 2024 Feb 20;21(2):e1004356. doi: 10.1371/journal.pmed.1004356. eCollection 2024 Feb. PLoS Med. 2024. PMID: 38377166 Free PMC article. Clinical Trial.
Exploring ecosocial contexts of alcohol use and misuse during the COVID-19 pandemic among urban refugee youth in Kampala, Uganda: Multi-method findings.
Logie CH, Okumu M, Admassu Z, MacKenzie F, Tailor L, Kortenaar JL, Perez-Brumer A, Ahmed R, Batte S, Hakiza R, Kibuuka Musoke D, Katisi B, Nakitende A, Juster RP, Marin MF, Kyambadde P. Logie CH, et al. Among authors: nakitende a. J Migr Health. 2024 Feb 8;9:100215. doi: 10.1016/j.jmh.2024.100215. eCollection 2024. J Migr Health. 2024. PMID: 38375158 Free PMC article.
31 results